Advertisement
Home Tags Terrorism

Tag: Terrorism

Many dermatologists report that they are not adequately prepared to deal with biological attacks and other manmade disasters

Many Dermatologists Not Ready to Respond to Biological Attacks

Less than three in 10 dermatologists received training in disaster preparedness and response
Based on repeated measures

Repeated Measures of 9/11-Related PTSD Tied to Mortality

Time-varying PTSD linked to increased risk for all-cause, cardiovascular, external-cause mortality
A newly developed checklist can rapidly identify anthrax cases after a suspected mass exposure

Novel Checklist Can Distinguish Anthrax Exposure From Other Illnesses

Checklist could minimize need for diagnostic testing after known or suspected population exposure
Among individuals with posttraumatic stress disorder

Terrorist Attack Victims With PTSD Have Higher Cancer Risk

Women with PTSD have higher risk for cancer than men, are more protected from circulatory issues
A psychological and social model provides insight into factors and triggers for radicalization among European youth recruited into Islam

New Model IDs Factors Tied to Muslim Youth Radicalization

Model provides a framework for prevention among European youth, with role for psychiatrists
TPOXX (tecovirimat) has been approved by the U.S. Food and Drug Administration to treat smallpox.

FDA Approves First Drug to Treat Smallpox

New treatment offers additional option should smallpox ever be used as a bioweapon
Posttraumatic stress disorder experienced by many rescuers and other first responders of 9/11 now appears linked to cognitive impairment and dementia

9/11 Responders May Be at Higher Risk for Early Dementia

WTC first responders who developed PTSD seem at greater risk of cognitive impairment
Anthim (obiltoxaximab) has been approved by the U.S. Food and Drug Administration to treat inhalational anthrax.

FDA Approves Anthim for Treating Inhalation Anthrax

Anthim, combined with certain antibacterial drugs, designed to neutralize anthrax toxins
Avelox (moxifloxacin) was approved by the U.S. Food and Drug Administration on Friday to treat plague

FDA Approves Avelox for Treatment of Plague

Yersinia pestis bacterium could be released intentionally in bioterrorism
Anthrasil

FDA Approves New Treatment for Anthrax

FDA cites preparedness for intentional release of anthrax